Upon completion of this course, participants should be able to:
Chapter 1: Introduction to Menopause and Vasomotor Symptoms
Definitions: perimenopause, menopause, postmenopause
Epidemiology and prevalence
Impact on quality of life
Burden on healthcare systems and under-treatment trends
Chapter 2: Anatomy and Physiology of the Female Reproductive and Neuroendocrine Systems
Ovarian function and hormonal regulation
Hypothalamic-pituitary-ovarian (HPO) axis
Thermoregulation and the hypothalamus
Neurotransmitters involved (KNDy neurons: kisspeptin, neurokinin B, dynorphin)
Chapter 3: Pathophysiology of Vasomotor Symptoms
Decline in estrogen and narrowing of thermoneutral zone
Mechanisms of hot flashes and night sweats
Role of central nervous system and temperature dysregulation
Emerging understanding of neurokinin signaling pathways
Risk factors (BMI, race/ethnicity, psychosocial stressors)
Chapter 4: Clinical Presentation and Symptom Variability
Characteristics of hot flashes and night sweats
Frequency, severity, and duration (often lasting years)
Associated symptoms:
Sleep disturbances
Mood/cognitive changes (“brain fog”)
Cardiovascular implications
Cultural and individual variability in symptom experience
Chapter 5: Assessment and Diagnosis
Clinical history and symptom tracking
Differential diagnosis (thyroid disorders, infection, malignancy)
Use of validated symptom scales
Identifying candidates for treatment
Chapter 6: Lifestyle and Non-Pharmacological Management
Weight management and exercise
Sleep hygiene strategies
Trigger avoidance (heat, alcohol, stress)
Mind-body therapies (CBT, mindfulness, relaxation)
Evidence limitations and patient counseling
Patient-centered education strategies
Chapter 7: Hormone Replacement Therapy (HRT)
Mechanism of action of estrogen ± progestogen
Efficacy (up to ~75–90% symptom reduction)
Routes of administration (oral, transdermal, vaginal)
Risks vs. benefits (WHI data evolution)
Contraindications and patient selection
Shared decision-making and individualized care
Chapter 8: Non-Hormonal Pharmacologic Treatments
SSRIs/SNRIs (e.g., paroxetine)
Gabapentinoids
Clonidine
Neurokinin-3 receptor antagonists (emerging therapies)
Indications for non-hormonal therapy
Comparative effectiveness and safety considerations
Chapter 9: Special Populations and Clinical Considerations
Women with contraindications to HRT (e.g., breast cancer)
Early/surgical menopause
Comorbid conditions (cardiovascular disease, obesity)
Health disparities and social determinants of health
Chapter 10: Nursing Implications and Patient Education
Role of nurses in menopause management
Counseling and communication strategies
Promoting adherence and follow-up
Interdisciplinary collaboration
Case studies and clinical application
Kendall is a 2022 Magna Cum Laude graduate from Tyler Junior College with an Associate Degree in Nursing and completed Pacific College of Health and Science’s RN-to-BSN in Holistic Nursing program in 2026, also graduating Magna Cum Laude.
In addition to her academic and professional accomplishments, Kendall serves as the Chief Operating Officer of Pedagogy Education, where she oversees the company’s day-to-day operations and contributes as an educational course author. Her combination of leadership experience, clinical knowledge, and passion for holistic health reflects her ongoing commitment to advancing both patient care and healthcare education.
Read Full BioSee our Accreditation Statements page to view our accreditation information.